The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of chemoradiotherapy (CRT) on local control and time without treatment in patients with locally advanced pancreatic cancer (LAPC) included in the international phase III LAP 07 study.
Florence Huguet
Consultant or Advisory Role - Merck Serono
Honoraria - Roche/Genentech
Pascal Hammel
Consultant or Advisory Role - Roche
Dewi Vernerey
No relevant relationships to disclose
David Goldstein
No relevant relationships to disclose
Jean Luc Van Laethem
No relevant relationships to disclose
Bengt Glimelius
No relevant relationships to disclose
Nigel Spry
No relevant relationships to disclose
Sophie Paget-Bailly
No relevant relationships to disclose
Franck Bonnetain
Consultant or Advisory Role - Invectys
Honoraria - Bristol-Myers Squibb; Merck Serono; Nestlé
Research Funding - Roche
Christophe Louvet
No relevant relationships to disclose